
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-01-16 17:49:32 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='bleu', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/custom_EMEA/orig_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[5e-06], lr_scheduler='inverse_sqrt', max_epoch=30, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=True, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='checkpoints/EMEA_15', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-01-16 17:49:33 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-01-16 17:49:33 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-01-16 17:49:33 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.de
2021-01-16 17:49:33 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.en
2021-01-16 17:49:33 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA valid de-en 151 examples
2021-01-16 17:49:39 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-01-16 17:49:39 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-01-16 17:49:39 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-01-16 17:49:46 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-01-16 17:49:46 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-16 17:49:46 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-01-16 17:49:46 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-16 17:49:46 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-01-16 17:49:46 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-01-16 17:49:54 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-01-16 17:49:54 | INFO | fairseq.trainer | loading train data for epoch 1
2021-01-16 17:49:54 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.de
2021-01-16 17:49:54 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.en
2021-01-16 17:49:54 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA train de-en 10001 examples
2021-01-16 17:49:54 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-16 17:49:56 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-01-16 17:49:56 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-01-16 17:49:59 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-01-16 17:50:00 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-01-16 17:50:13 | INFO | train_inner | epoch 001:    104 / 139 loss=3.655, nll_loss=1.942, ppl=3.84, wps=14126.4, ups=5.73, wpb=2465.8, bsz=72.7, num_updates=100, lr=1.25e-07, gnorm=4.151, loss_scale=12, train_wall=17, wall=28
2021-01-16 17:50:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:50:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:50:21 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:50:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:50:21 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:50:22 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:50:22 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:50:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:50:26 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:50:26 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.96 | nll_loss 2.246 | ppl 4.74 | bleu 31.75 | wps 758.7 | wpb 1083 | bsz 37.8 | num_updates 135
2021-01-16 17:50:26 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:50:40 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 1 @ 135 updates, score 31.75) (writing took 14.547510691918433 seconds)
2021-01-16 17:50:40 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-01-16 17:50:40 | INFO | train | epoch 001 | loss 3.64 | nll_loss 1.925 | ppl 3.8 | wps 7481 | ups 3.04 | wpb 2458.9 | bsz 72.3 | num_updates 135 | lr 1.6875e-07 | gnorm 4.142 | loss_scale 12 | train_wall 24 | wall 54
2021-01-16 17:50:40 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-16 17:50:51 | INFO | train_inner | epoch 002:     65 / 139 loss=3.625, nll_loss=1.908, ppl=3.75, wps=6533.8, ups=2.63, wpb=2487.4, bsz=75, num_updates=200, lr=2.5e-07, gnorm=4.06, loss_scale=8, train_wall=17, wall=66
2021-01-16 17:51:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:51:04 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:51:04 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:51:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:51:05 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:51:06 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:51:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:51:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:51:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:51:09 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.934 | nll_loss 2.22 | ppl 4.66 | bleu 31.83 | wps 792.6 | wpb 1083 | bsz 37.8 | num_updates 274 | best_bleu 31.83
2021-01-16 17:51:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:51:26 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 2 @ 274 updates, score 31.83) (writing took 16.675332675222307 seconds)
2021-01-16 17:51:26 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-01-16 17:51:26 | INFO | train | epoch 002 | loss 3.648 | nll_loss 1.936 | ppl 3.83 | wps 7489.8 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 274 | lr 3.425e-07 | gnorm 4.209 | loss_scale 8 | train_wall 24 | wall 100
2021-01-16 17:51:26 | INFO | fairseq_cli.train | begin training epoch 2
2021-01-16 17:51:30 | INFO | train_inner | epoch 003:     26 / 139 loss=3.687, nll_loss=1.981, ppl=3.95, wps=6029.9, ups=2.58, wpb=2333, bsz=67, num_updates=300, lr=3.75e-07, gnorm=4.416, loss_scale=8, train_wall=17, wall=104
2021-01-16 17:51:47 | INFO | train_inner | epoch 003:    126 / 139 loss=3.6, nll_loss=1.888, ppl=3.7, wps=14777.9, ups=5.83, wpb=2535.2, bsz=75.8, num_updates=400, lr=5e-07, gnorm=4.156, loss_scale=8, train_wall=17, wall=122
2021-01-16 17:51:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:51:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:51:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:51:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:51:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:51:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:51:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:51:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:51:55 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:51:55 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.886 | nll_loss 2.171 | ppl 4.5 | bleu 32.31 | wps 790.7 | wpb 1083 | bsz 37.8 | num_updates 413 | best_bleu 32.31
2021-01-16 17:51:55 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:52:11 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 3 @ 413 updates, score 32.31) (writing took 16.529794874601066 seconds)
2021-01-16 17:52:11 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-01-16 17:52:11 | INFO | train | epoch 003 | loss 3.615 | nll_loss 1.904 | ppl 3.74 | wps 7513.1 | ups 3.06 | wpb 2458.3 | bsz 71.9 | num_updates 413 | lr 5.1625e-07 | gnorm 4.133 | loss_scale 8 | train_wall 24 | wall 146
2021-01-16 17:52:11 | INFO | fairseq_cli.train | begin training epoch 3
2021-01-16 17:52:26 | INFO | train_inner | epoch 004:     87 / 139 loss=3.51, nll_loss=1.79, ppl=3.46, wps=6515.2, ups=2.57, wpb=2538.2, bsz=71, num_updates=500, lr=6.25e-07, gnorm=3.785, loss_scale=8, train_wall=17, wall=161
2021-01-16 17:52:35 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:52:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:52:35 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:52:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:52:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:52:37 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:52:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:52:40 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:52:40 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:52:40 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 3.825 | nll_loss 2.108 | ppl 4.31 | bleu 32.35 | wps 805 | wpb 1083 | bsz 37.8 | num_updates 552 | best_bleu 32.35
2021-01-16 17:52:40 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:52:57 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 4 @ 552 updates, score 32.35) (writing took 16.683081199415028 seconds)
2021-01-16 17:52:57 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-01-16 17:52:57 | INFO | train | epoch 004 | loss 3.567 | nll_loss 1.855 | ppl 3.62 | wps 7500.4 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 552 | lr 6.9e-07 | gnorm 3.908 | loss_scale 8 | train_wall 24 | wall 191
2021-01-16 17:52:57 | INFO | fairseq_cli.train | begin training epoch 4
2021-01-16 17:53:05 | INFO | train_inner | epoch 005:     48 / 139 loss=3.58, nll_loss=1.872, ppl=3.66, wps=6182.4, ups=2.56, wpb=2411.9, bsz=72.3, num_updates=600, lr=7.5e-07, gnorm=3.782, loss_scale=8, train_wall=17, wall=200
2021-01-16 17:53:21 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:53:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:53:21 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:53:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:53:22 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:53:23 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:53:23 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:53:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:53:26 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:53:26 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 3.76 | nll_loss 2.037 | ppl 4.1 | bleu 33.96 | wps 784.1 | wpb 1083 | bsz 37.8 | num_updates 691 | best_bleu 33.96
2021-01-16 17:53:26 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:53:44 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 5 @ 691 updates, score 33.96) (writing took 17.88227556599304 seconds)
2021-01-16 17:53:44 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-01-16 17:53:44 | INFO | train | epoch 005 | loss 3.511 | nll_loss 1.797 | ppl 3.47 | wps 7288.7 | ups 2.96 | wpb 2458.3 | bsz 71.9 | num_updates 691 | lr 8.6375e-07 | gnorm 3.665 | loss_scale 8 | train_wall 24 | wall 238
2021-01-16 17:53:44 | INFO | fairseq_cli.train | begin training epoch 5
2021-01-16 17:53:45 | INFO | train_inner | epoch 006:      9 / 139 loss=3.503, nll_loss=1.787, ppl=3.45, wps=6050.9, ups=2.51, wpb=2415.5, bsz=69.1, num_updates=700, lr=8.75e-07, gnorm=3.911, loss_scale=8, train_wall=17, wall=239
2021-01-16 17:54:02 | INFO | train_inner | epoch 006:    109 / 139 loss=3.429, nll_loss=1.707, ppl=3.26, wps=14623.4, ups=5.79, wpb=2527.8, bsz=73.9, num_updates=800, lr=1e-06, gnorm=3.307, loss_scale=8, train_wall=17, wall=257
2021-01-16 17:54:07 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:54:08 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:54:08 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:54:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:54:09 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:54:10 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:54:10 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:54:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:54:13 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:54:13 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 3.701 | nll_loss 1.97 | ppl 3.92 | bleu 36.46 | wps 745 | wpb 1083 | bsz 37.8 | num_updates 830 | best_bleu 36.46
2021-01-16 17:54:13 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:54:33 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 6 @ 830 updates, score 36.46) (writing took 19.81386992521584 seconds)
2021-01-16 17:54:33 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-01-16 17:54:33 | INFO | train | epoch 006 | loss 3.455 | nll_loss 1.735 | ppl 3.33 | wps 6967.6 | ups 2.83 | wpb 2458.3 | bsz 71.9 | num_updates 830 | lr 1.0375e-06 | gnorm 3.515 | loss_scale 8 | train_wall 24 | wall 287
2021-01-16 17:54:33 | INFO | fairseq_cli.train | begin training epoch 6
2021-01-16 17:54:44 | INFO | train_inner | epoch 007:     70 / 139 loss=3.477, nll_loss=1.759, ppl=3.39, wps=5493.8, ups=2.38, wpb=2306.6, bsz=69, num_updates=900, lr=1.125e-06, gnorm=3.571, loss_scale=8, train_wall=17, wall=299
2021-01-16 17:54:56 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:54:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:54:57 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:54:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 17:54:58 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:54:59 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:54:59 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:55:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:55:02 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:55:02 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 3.639 | nll_loss 1.898 | ppl 3.73 | bleu 36.82 | wps 750.4 | wpb 1083 | bsz 37.8 | num_updates 969 | best_bleu 36.82
2021-01-16 17:55:02 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:55:19 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 7 @ 969 updates, score 36.82) (writing took 17.000066155102104 seconds)
2021-01-16 17:55:19 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-01-16 17:55:19 | INFO | train | epoch 007 | loss 3.399 | nll_loss 1.671 | ppl 3.18 | wps 7402.1 | ups 3.01 | wpb 2458.3 | bsz 71.9 | num_updates 969 | lr 1.21125e-06 | gnorm 3.344 | loss_scale 8 | train_wall 24 | wall 333
2021-01-16 17:55:19 | INFO | fairseq_cli.train | begin training epoch 7
2021-01-16 17:55:24 | INFO | train_inner | epoch 008:     31 / 139 loss=3.35, nll_loss=1.616, ppl=3.07, wps=6494.4, ups=2.51, wpb=2584.4, bsz=78.4, num_updates=1000, lr=1.25e-06, gnorm=3.04, loss_scale=8, train_wall=17, wall=339
2021-01-16 17:55:41 | INFO | train_inner | epoch 008:    131 / 139 loss=3.353, nll_loss=1.616, ppl=3.06, wps=14305.6, ups=5.83, wpb=2451.8, bsz=69.4, num_updates=1100, lr=1.375e-06, gnorm=3.118, loss_scale=8, train_wall=17, wall=356
2021-01-16 17:55:43 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:55:43 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:55:43 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:55:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:55:44 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:55:45 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:55:45 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:55:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:55:47 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:55:47 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 3.58 | nll_loss 1.829 | ppl 3.55 | bleu 39.49 | wps 956.9 | wpb 1083 | bsz 37.8 | num_updates 1108 | best_bleu 39.49
2021-01-16 17:55:47 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:56:04 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 8 @ 1108 updates, score 39.49) (writing took 17.289962404873222 seconds)
2021-01-16 17:56:04 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-01-16 17:56:04 | INFO | train | epoch 008 | loss 3.345 | nll_loss 1.608 | ppl 3.05 | wps 7516.1 | ups 3.06 | wpb 2458.3 | bsz 71.9 | num_updates 1108 | lr 1.385e-06 | gnorm 3.201 | loss_scale 8 | train_wall 24 | wall 379
2021-01-16 17:56:04 | INFO | fairseq_cli.train | begin training epoch 8
2021-01-16 17:56:20 | INFO | train_inner | epoch 009:     92 / 139 loss=3.305, nll_loss=1.561, ppl=2.95, wps=6205.6, ups=2.59, wpb=2396, bsz=67.8, num_updates=1200, lr=1.5e-06, gnorm=3.292, loss_scale=8, train_wall=17, wall=394
2021-01-16 17:56:28 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:56:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:56:29 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:56:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:56:29 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:56:30 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:56:30 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:56:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:56:33 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:56:33 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 3.525 | nll_loss 1.764 | ppl 3.4 | bleu 39.8 | wps 914.2 | wpb 1083 | bsz 37.8 | num_updates 1247 | best_bleu 39.8
2021-01-16 17:56:33 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:56:49 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 9 @ 1247 updates, score 39.8) (writing took 16.866503093857318 seconds)
2021-01-16 17:56:49 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-01-16 17:56:49 | INFO | train | epoch 009 | loss 3.294 | nll_loss 1.548 | ppl 2.92 | wps 7564 | ups 3.08 | wpb 2458.3 | bsz 71.9 | num_updates 1247 | lr 1.55875e-06 | gnorm 3.088 | loss_scale 8 | train_wall 24 | wall 424
2021-01-16 17:56:49 | INFO | fairseq_cli.train | begin training epoch 9
2021-01-16 17:56:59 | INFO | train_inner | epoch 010:     53 / 139 loss=3.257, nll_loss=1.505, ppl=2.84, wps=6405.7, ups=2.59, wpb=2473.2, bsz=73.2, num_updates=1300, lr=1.625e-06, gnorm=2.981, loss_scale=8, train_wall=17, wall=433
2021-01-16 17:57:13 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:57:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-16 17:57:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:57:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:57:14 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:57:15 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:57:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:57:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-16 17:57:18 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:57:18 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 3.466 | nll_loss 1.697 | ppl 3.24 | bleu 40.43 | wps 936.8 | wpb 1083 | bsz 37.8 | num_updates 1386 | best_bleu 40.43
2021-01-16 17:57:18 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:57:34 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 10 @ 1386 updates, score 40.43) (writing took 16.661353532690555 seconds)
2021-01-16 17:57:34 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-01-16 17:57:34 | INFO | train | epoch 010 | loss 3.245 | nll_loss 1.491 | ppl 2.81 | wps 7610.4 | ups 3.1 | wpb 2458.3 | bsz 71.9 | num_updates 1386 | lr 1.7325e-06 | gnorm 3.003 | loss_scale 8 | train_wall 24 | wall 469
2021-01-16 17:57:34 | INFO | fairseq_cli.train | begin training epoch 10
2021-01-16 17:57:37 | INFO | train_inner | epoch 011:     14 / 139 loss=3.244, nll_loss=1.489, ppl=2.81, wps=6549, ups=2.61, wpb=2507.6, bsz=71.6, num_updates=1400, lr=1.75e-06, gnorm=2.976, loss_scale=8, train_wall=17, wall=471
2021-01-16 17:57:54 | INFO | train_inner | epoch 011:    114 / 139 loss=3.197, nll_loss=1.435, ppl=2.7, wps=14209.5, ups=5.93, wpb=2396.5, bsz=73.5, num_updates=1500, lr=1.875e-06, gnorm=3.054, loss_scale=8, train_wall=17, wall=488
2021-01-16 17:57:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:57:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:57:59 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:57:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:57:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:58:00 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:58:00 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:58:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial with 182 patients) .In the trials, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-16 17:58:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:58:03 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 3.413 | nll_loss 1.635 | ppl 3.11 | bleu 40.68 | wps 900.7 | wpb 1083 | bsz 37.8 | num_updates 1525 | best_bleu 40.68
2021-01-16 17:58:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:58:21 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 11 @ 1525 updates, score 40.68) (writing took 18.439828240778297 seconds)
2021-01-16 17:58:21 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-01-16 17:58:21 | INFO | train | epoch 011 | loss 3.197 | nll_loss 1.435 | ppl 2.7 | wps 7292.7 | ups 2.97 | wpb 2458.3 | bsz 71.9 | num_updates 1525 | lr 1.90625e-06 | gnorm 2.96 | loss_scale 8 | train_wall 24 | wall 516
2021-01-16 17:58:21 | INFO | fairseq_cli.train | begin training epoch 11
2021-01-16 17:58:34 | INFO | train_inner | epoch 012:     75 / 139 loss=3.144, nll_loss=1.374, ppl=2.59, wps=6300.8, ups=2.47, wpb=2547.2, bsz=72.2, num_updates=1600, lr=2e-06, gnorm=2.738, loss_scale=8, train_wall=17, wall=528
2021-01-16 17:58:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:58:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:58:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:58:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:58:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:58:47 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:58:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:58:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial with 182 patients) .In the trials, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-16 17:58:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:58:50 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 3.36 | nll_loss 1.574 | ppl 2.98 | bleu 41.47 | wps 906.4 | wpb 1083 | bsz 37.8 | num_updates 1664 | best_bleu 41.47
2021-01-16 17:58:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:59:08 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 12 @ 1664 updates, score 41.47) (writing took 18.25318479212001 seconds)
2021-01-16 17:59:08 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-01-16 17:59:08 | INFO | train | epoch 012 | loss 3.154 | nll_loss 1.385 | ppl 2.61 | wps 7329.8 | ups 2.98 | wpb 2458.3 | bsz 71.9 | num_updates 1664 | lr 2.08e-06 | gnorm 2.829 | loss_scale 8 | train_wall 24 | wall 562
2021-01-16 17:59:08 | INFO | fairseq_cli.train | begin training epoch 12
2021-01-16 17:59:14 | INFO | train_inner | epoch 013:     36 / 139 loss=3.162, nll_loss=1.396, ppl=2.63, wps=6050.1, ups=2.51, wpb=2411.6, bsz=73.8, num_updates=1700, lr=2.125e-06, gnorm=2.907, loss_scale=8, train_wall=17, wall=568
2021-01-16 17:59:31 | INFO | train_inner | epoch 013:    136 / 139 loss=3.102, nll_loss=1.325, ppl=2.51, wps=14410, ups=5.84, wpb=2466.8, bsz=70.3, num_updates=1800, lr=2.25e-06, gnorm=2.689, loss_scale=8, train_wall=17, wall=585
2021-01-16 17:59:32 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 17:59:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:59:32 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 17:59:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 17:59:33 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 17:59:34 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 17:59:34 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 17:59:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-16 17:59:36 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 17:59:36 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 3.311 | nll_loss 1.515 | ppl 2.86 | bleu 43.02 | wps 950.4 | wpb 1083 | bsz 37.8 | num_updates 1803 | best_bleu 43.02
2021-01-16 17:59:36 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 17:59:53 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 13 @ 1803 updates, score 43.02) (writing took 17.40915053896606 seconds)
2021-01-16 17:59:53 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-01-16 17:59:53 | INFO | train | epoch 013 | loss 3.106 | nll_loss 1.331 | ppl 2.52 | wps 7493.8 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 1803 | lr 2.25375e-06 | gnorm 2.743 | loss_scale 8 | train_wall 24 | wall 608
2021-01-16 17:59:53 | INFO | fairseq_cli.train | begin training epoch 13
2021-01-16 18:00:10 | INFO | train_inner | epoch 014:     97 / 139 loss=3.045, nll_loss=1.261, ppl=2.4, wps=6440.2, ups=2.56, wpb=2515.9, bsz=73, num_updates=1900, lr=2.375e-06, gnorm=2.664, loss_scale=8, train_wall=17, wall=625
2021-01-16 18:00:17 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:00:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:00:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:00:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:00:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:00:19 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:00:19 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:00:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6 month treatment with Actrapid.
2021-01-16 18:00:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:00:22 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 3.26 | nll_loss 1.458 | ppl 2.75 | bleu 43.83 | wps 916.7 | wpb 1083 | bsz 37.8 | num_updates 1942 | best_bleu 43.83
2021-01-16 18:00:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:00:39 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 14 @ 1942 updates, score 43.83) (writing took 17.270613378379494 seconds)
2021-01-16 18:00:39 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-01-16 18:00:39 | INFO | train | epoch 014 | loss 3.063 | nll_loss 1.28 | ppl 2.43 | wps 7486.4 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 1942 | lr 2.4275e-06 | gnorm 2.687 | loss_scale 8 | train_wall 24 | wall 653
2021-01-16 18:00:39 | INFO | fairseq_cli.train | begin training epoch 14
2021-01-16 18:00:49 | INFO | train_inner | epoch 015:     58 / 139 loss=3.035, nll_loss=1.249, ppl=2.38, wps=6267.8, ups=2.57, wpb=2439, bsz=72.1, num_updates=2000, lr=2.5e-06, gnorm=2.651, loss_scale=8, train_wall=17, wall=663
2021-01-16 18:01:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:01:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:01:03 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:01:04 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:01:04 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:01:05 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:01:05 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:01:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6 month treatment with Actrapid.
2021-01-16 18:01:07 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:01:07 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 3.213 | nll_loss 1.401 | ppl 2.64 | bleu 44.67 | wps 917.8 | wpb 1083 | bsz 37.8 | num_updates 2081 | best_bleu 44.67
2021-01-16 18:01:07 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:01:24 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 15 @ 2081 updates, score 44.67) (writing took 16.105240473989397 seconds)
2021-01-16 18:01:24 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-01-16 18:01:24 | INFO | train | epoch 015 | loss 3.019 | nll_loss 1.231 | ppl 2.35 | wps 7681.9 | ups 3.12 | wpb 2458.3 | bsz 71.9 | num_updates 2081 | lr 2.60125e-06 | gnorm 2.641 | loss_scale 8 | train_wall 24 | wall 698
2021-01-16 18:01:24 | INFO | fairseq_cli.train | begin training epoch 15
2021-01-16 18:01:27 | INFO | train_inner | epoch 016:     19 / 139 loss=3.049, nll_loss=1.263, ppl=2.4, wps=6397.9, ups=2.65, wpb=2416.4, bsz=67.3, num_updates=2100, lr=2.625e-06, gnorm=2.686, loss_scale=8, train_wall=17, wall=701
2021-01-16 18:01:44 | INFO | train_inner | epoch 016:    119 / 139 loss=2.946, nll_loss=1.147, ppl=2.21, wps=14589.4, ups=5.84, wpb=2496.3, bsz=74.5, num_updates=2200, lr=2.75e-06, gnorm=2.541, loss_scale=8, train_wall=17, wall=718
2021-01-16 18:01:47 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:01:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:01:48 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:01:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 18:01:49 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:01:49 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:01:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:01:52 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:01:52 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:01:52 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 3.165 | nll_loss 1.346 | ppl 2.54 | bleu 46.45 | wps 972 | wpb 1083 | bsz 37.8 | num_updates 2220 | best_bleu 46.45
2021-01-16 18:01:52 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:02:08 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 16 @ 2220 updates, score 46.45) (writing took 16.473604016005993 seconds)
2021-01-16 18:02:08 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-01-16 18:02:08 | INFO | train | epoch 016 | loss 2.976 | nll_loss 1.18 | ppl 2.27 | wps 7665.1 | ups 3.12 | wpb 2458.3 | bsz 71.9 | num_updates 2220 | lr 2.775e-06 | gnorm 2.583 | loss_scale 8 | train_wall 24 | wall 742
2021-01-16 18:02:08 | INFO | fairseq_cli.train | begin training epoch 16
2021-01-16 18:02:22 | INFO | train_inner | epoch 017:     80 / 139 loss=2.965, nll_loss=1.167, ppl=2.25, wps=6415.5, ups=2.64, wpb=2431.2, bsz=67.6, num_updates=2300, lr=2.875e-06, gnorm=2.59, loss_scale=8, train_wall=17, wall=756
2021-01-16 18:02:32 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:02:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:02:33 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:02:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 18:02:33 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:02:34 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:02:34 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:02:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:02:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:02:37 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 3.122 | nll_loss 1.295 | ppl 2.45 | bleu 47.6 | wps 904.6 | wpb 1083 | bsz 37.8 | num_updates 2359 | best_bleu 47.6
2021-01-16 18:02:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:02:54 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 17 @ 2359 updates, score 47.6) (writing took 17.121341404970735 seconds)
2021-01-16 18:02:54 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-01-16 18:02:54 | INFO | train | epoch 017 | loss 2.933 | nll_loss 1.132 | ppl 2.19 | wps 7500.3 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 2359 | lr 2.94875e-06 | gnorm 2.538 | loss_scale 8 | train_wall 24 | wall 788
2021-01-16 18:02:54 | INFO | fairseq_cli.train | begin training epoch 17
2021-01-16 18:03:01 | INFO | train_inner | epoch 018:     41 / 139 loss=2.912, nll_loss=1.107, ppl=2.15, wps=6319.9, ups=2.57, wpb=2457.9, bsz=79, num_updates=2400, lr=3e-06, gnorm=2.547, loss_scale=8, train_wall=17, wall=795
2021-01-16 18:03:17 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:03:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:03:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:03:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-16 18:03:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:03:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:03:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:03:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:03:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:03:22 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 3.083 | nll_loss 1.248 | ppl 2.38 | bleu 49.11 | wps 912.8 | wpb 1083 | bsz 37.8 | num_updates 2498 | best_bleu 49.11
2021-01-16 18:03:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:03:38 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 18 @ 2498 updates, score 49.11) (writing took 15.780313558876514 seconds)
2021-01-16 18:03:38 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-01-16 18:03:38 | INFO | train | epoch 018 | loss 2.891 | nll_loss 1.084 | ppl 2.12 | wps 7743.5 | ups 3.15 | wpb 2458.3 | bsz 71.9 | num_updates 2498 | lr 3.1225e-06 | gnorm 2.478 | loss_scale 8 | train_wall 24 | wall 832
2021-01-16 18:03:38 | INFO | fairseq_cli.train | begin training epoch 18
2021-01-16 18:03:38 | INFO | train_inner | epoch 019:      2 / 139 loss=2.884, nll_loss=1.075, ppl=2.11, wps=6509.5, ups=2.67, wpb=2439.4, bsz=69.4, num_updates=2500, lr=3.125e-06, gnorm=2.426, loss_scale=8, train_wall=17, wall=833
2021-01-16 18:03:56 | INFO | train_inner | epoch 019:    102 / 139 loss=2.874, nll_loss=1.064, ppl=2.09, wps=14703.9, ups=5.78, wpb=2545.3, bsz=73.6, num_updates=2600, lr=3.25e-06, gnorm=2.446, loss_scale=8, train_wall=17, wall=850
2021-01-16 18:04:02 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:04:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:04:02 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:04:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:04:03 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:04:04 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:04:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:04:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:04:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:04:06 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 3.043 | nll_loss 1.2 | ppl 2.3 | bleu 50.3 | wps 953.2 | wpb 1083 | bsz 37.8 | num_updates 2637 | best_bleu 50.3
2021-01-16 18:04:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:04:23 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 19 @ 2637 updates, score 50.3) (writing took 16.699664123822004 seconds)
2021-01-16 18:04:23 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-01-16 18:04:23 | INFO | train | epoch 019 | loss 2.852 | nll_loss 1.039 | ppl 2.05 | wps 7611.2 | ups 3.1 | wpb 2458.3 | bsz 71.9 | num_updates 2637 | lr 3.29625e-06 | gnorm 2.442 | loss_scale 8 | train_wall 24 | wall 877
2021-01-16 18:04:23 | INFO | fairseq_cli.train | begin training epoch 19
2021-01-16 18:04:34 | INFO | train_inner | epoch 020:     63 / 139 loss=2.815, nll_loss=0.997, ppl=2, wps=6215.4, ups=2.63, wpb=2364.7, bsz=73.9, num_updates=2700, lr=3.375e-06, gnorm=2.413, loss_scale=8, train_wall=17, wall=888
2021-01-16 18:04:47 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:04:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:04:47 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:04:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:04:48 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:04:49 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:04:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:04:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these studies? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:04:51 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:04:51 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 3.007 | nll_loss 1.159 | ppl 2.23 | bleu 52.26 | wps 907.1 | wpb 1083 | bsz 37.8 | num_updates 2776 | best_bleu 52.26
2021-01-16 18:04:51 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:05:09 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 20 @ 2776 updates, score 52.26) (writing took 17.717629830818623 seconds)
2021-01-16 18:05:09 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-01-16 18:05:09 | INFO | train | epoch 020 | loss 2.811 | nll_loss 0.992 | ppl 1.99 | wps 7414.2 | ups 3.02 | wpb 2458.3 | bsz 71.9 | num_updates 2776 | lr 3.47e-06 | gnorm 2.347 | loss_scale 8 | train_wall 24 | wall 923
2021-01-16 18:05:09 | INFO | fairseq_cli.train | begin training epoch 20
2021-01-16 18:05:13 | INFO | train_inner | epoch 021:     24 / 139 loss=2.803, nll_loss=0.981, ppl=1.97, wps=6190.9, ups=2.54, wpb=2437.6, bsz=64.6, num_updates=2800, lr=3.5e-06, gnorm=2.358, loss_scale=8, train_wall=17, wall=927
2021-01-16 18:05:30 | INFO | train_inner | epoch 021:    124 / 139 loss=2.748, nll_loss=0.92, ppl=1.89, wps=14741.3, ups=5.84, wpb=2522.9, bsz=77, num_updates=2900, lr=3.625e-06, gnorm=2.229, loss_scale=8, train_wall=17, wall=944
2021-01-16 18:05:33 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:05:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:05:33 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:05:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:05:34 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:05:35 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:05:35 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:05:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these studies? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:05:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:05:37 | INFO | valid | epoch 021 | valid on 'valid' subset | loss 2.972 | nll_loss 1.118 | ppl 2.17 | bleu 53.69 | wps 910.4 | wpb 1083 | bsz 37.8 | num_updates 2915 | best_bleu 53.69
2021-01-16 18:05:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:05:55 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 21 @ 2915 updates, score 53.69) (writing took 17.38991373265162 seconds)
2021-01-16 18:05:55 | INFO | fairseq_cli.train | end of epoch 21 (average epoch stats below)
2021-01-16 18:05:55 | INFO | train | epoch 021 | loss 2.774 | nll_loss 0.949 | ppl 1.93 | wps 7467.9 | ups 3.04 | wpb 2458.3 | bsz 71.9 | num_updates 2915 | lr 3.64375e-06 | gnorm 2.308 | loss_scale 8 | train_wall 24 | wall 969
2021-01-16 18:05:55 | INFO | fairseq_cli.train | begin training epoch 21
2021-01-16 18:06:09 | INFO | train_inner | epoch 022:     85 / 139 loss=2.733, nll_loss=0.903, ppl=1.87, wps=6269.6, ups=2.55, wpb=2455.5, bsz=70.6, num_updates=3000, lr=3.75e-06, gnorm=2.222, loss_scale=8, train_wall=17, wall=984
2021-01-16 18:06:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:06:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:06:19 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:06:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:06:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:06:21 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:06:21 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:06:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has actrapid shown in these studies? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-01-16 18:06:23 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:06:23 | INFO | valid | epoch 022 | valid on 'valid' subset | loss 2.937 | nll_loss 1.077 | ppl 2.11 | bleu 55.57 | wps 949.3 | wpb 1083 | bsz 37.8 | num_updates 3054 | best_bleu 55.57
2021-01-16 18:06:23 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:06:40 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 22 @ 3054 updates, score 55.57) (writing took 17.52077523386106 seconds)
2021-01-16 18:06:40 | INFO | fairseq_cli.train | end of epoch 22 (average epoch stats below)
2021-01-16 18:06:40 | INFO | train | epoch 022 | loss 2.737 | nll_loss 0.907 | ppl 1.88 | wps 7470.8 | ups 3.04 | wpb 2458.3 | bsz 71.9 | num_updates 3054 | lr 3.8175e-06 | gnorm 2.258 | loss_scale 8 | train_wall 24 | wall 1015
2021-01-16 18:06:40 | INFO | fairseq_cli.train | begin training epoch 22
2021-01-16 18:06:48 | INFO | train_inner | epoch 023:     46 / 139 loss=2.744, nll_loss=0.914, ppl=1.88, wps=6250.8, ups=2.56, wpb=2442.1, bsz=74, num_updates=3100, lr=3.875e-06, gnorm=2.321, loss_scale=8, train_wall=17, wall=1023
2021-01-16 18:07:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:07:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:07:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:07:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:07:05 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:07:06 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:07:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:07:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:07:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:07:09 | INFO | valid | epoch 023 | valid on 'valid' subset | loss 2.902 | nll_loss 1.035 | ppl 2.05 | bleu 56.71 | wps 895.5 | wpb 1083 | bsz 37.8 | num_updates 3193 | best_bleu 56.71
2021-01-16 18:07:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:07:26 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 23 @ 3193 updates, score 56.71) (writing took 17.219295997172594 seconds)
2021-01-16 18:07:26 | INFO | fairseq_cli.train | end of epoch 23 (average epoch stats below)
2021-01-16 18:07:26 | INFO | train | epoch 023 | loss 2.699 | nll_loss 0.864 | ppl 1.82 | wps 7485.5 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 3193 | lr 3.99125e-06 | gnorm 2.2 | loss_scale 8 | train_wall 24 | wall 1060
2021-01-16 18:07:26 | INFO | fairseq_cli.train | begin training epoch 23
2021-01-16 18:07:27 | INFO | train_inner | epoch 024:      7 / 139 loss=2.695, nll_loss=0.86, ppl=1.81, wps=6304.9, ups=2.57, wpb=2457, bsz=69.3, num_updates=3200, lr=4e-06, gnorm=2.157, loss_scale=8, train_wall=17, wall=1062
2021-01-16 18:07:44 | INFO | train_inner | epoch 024:    107 / 139 loss=2.658, nll_loss=0.816, ppl=1.76, wps=14582, ups=5.84, wpb=2498.6, bsz=74.9, num_updates=3300, lr=4.125e-06, gnorm=2.1, loss_scale=8, train_wall=17, wall=1079
2021-01-16 18:07:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:07:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:07:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:07:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-16 18:07:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:07:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:07:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:07:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:07:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:07:54 | INFO | valid | epoch 024 | valid on 'valid' subset | loss 2.866 | nll_loss 0.99 | ppl 1.99 | bleu 58.62 | wps 909.2 | wpb 1083 | bsz 37.8 | num_updates 3332 | best_bleu 58.62
2021-01-16 18:07:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:08:12 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 24 @ 3332 updates, score 58.62) (writing took 17.464114874135703 seconds)
2021-01-16 18:08:12 | INFO | fairseq_cli.train | end of epoch 24 (average epoch stats below)
2021-01-16 18:08:12 | INFO | train | epoch 024 | loss 2.666 | nll_loss 0.826 | ppl 1.77 | wps 7448.4 | ups 3.03 | wpb 2458.3 | bsz 71.9 | num_updates 3332 | lr 4.165e-06 | gnorm 2.152 | loss_scale 8 | train_wall 24 | wall 1106
2021-01-16 18:08:12 | INFO | fairseq_cli.train | begin training epoch 24
2021-01-16 18:08:23 | INFO | train_inner | epoch 025:     68 / 139 loss=2.659, nll_loss=0.817, ppl=1.76, wps=6118.6, ups=2.57, wpb=2379.9, bsz=71, num_updates=3400, lr=4.25e-06, gnorm=2.183, loss_scale=8, train_wall=17, wall=1118
2021-01-16 18:08:36 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:08:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:08:36 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:08:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-16 18:08:37 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:08:38 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:08:38 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:08:40 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:08:40 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:08:40 | INFO | valid | epoch 025 | valid on 'valid' subset | loss 2.835 | nll_loss 0.956 | ppl 1.94 | bleu 60.8 | wps 975.6 | wpb 1083 | bsz 37.8 | num_updates 3471 | best_bleu 60.8
2021-01-16 18:08:40 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:08:57 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 25 @ 3471 updates, score 60.8) (writing took 17.5535054015927 seconds)
2021-01-16 18:08:57 | INFO | fairseq_cli.train | end of epoch 25 (average epoch stats below)
2021-01-16 18:08:57 | INFO | train | epoch 025 | loss 2.632 | nll_loss 0.787 | ppl 1.73 | wps 7490.1 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 3471 | lr 4.33875e-06 | gnorm 2.094 | loss_scale 8 | train_wall 24 | wall 1152
2021-01-16 18:08:57 | INFO | fairseq_cli.train | begin training epoch 25
2021-01-16 18:09:02 | INFO | train_inner | epoch 026:     29 / 139 loss=2.595, nll_loss=0.748, ppl=1.68, wps=6364, ups=2.56, wpb=2488.4, bsz=68.1, num_updates=3500, lr=4.375e-06, gnorm=2.006, loss_scale=8, train_wall=17, wall=1157
2021-01-16 18:09:20 | INFO | train_inner | epoch 026:    129 / 139 loss=2.608, nll_loss=0.759, ppl=1.69, wps=14486.6, ups=5.83, wpb=2483.1, bsz=73.9, num_updates=3600, lr=4.5e-06, gnorm=2.065, loss_scale=8, train_wall=17, wall=1174
2021-01-16 18:09:21 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:09:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:09:22 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:09:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-16 18:09:22 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:09:24 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:09:24 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:09:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:09:25 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:09:25 | INFO | valid | epoch 026 | valid on 'valid' subset | loss 2.808 | nll_loss 0.922 | ppl 1.89 | bleu 66.43 | wps 1025.5 | wpb 1083 | bsz 37.8 | num_updates 3610 | best_bleu 66.43
2021-01-16 18:09:25 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:09:42 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 26 @ 3610 updates, score 66.43) (writing took 16.663012370001525 seconds)
2021-01-16 18:09:42 | INFO | fairseq_cli.train | end of epoch 26 (average epoch stats below)
2021-01-16 18:09:42 | INFO | train | epoch 026 | loss 2.6 | nll_loss 0.751 | ppl 1.68 | wps 7659.6 | ups 3.12 | wpb 2458.3 | bsz 71.9 | num_updates 3610 | lr 4.5125e-06 | gnorm 2.02 | loss_scale 8 | train_wall 24 | wall 1196
2021-01-16 18:09:42 | INFO | fairseq_cli.train | begin training epoch 26
2021-01-16 18:09:58 | INFO | train_inner | epoch 027:     90 / 139 loss=2.576, nll_loss=0.722, ppl=1.65, wps=6558.9, ups=2.63, wpb=2497.2, bsz=72.2, num_updates=3700, lr=4.625e-06, gnorm=1.925, loss_scale=8, train_wall=17, wall=1212
2021-01-16 18:10:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:10:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:10:06 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:10:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-16 18:10:07 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:10:08 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:10:08 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:10:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:10:10 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:10:10 | INFO | valid | epoch 027 | valid on 'valid' subset | loss 2.787 | nll_loss 0.894 | ppl 1.86 | bleu 67.76 | wps 1011.1 | wpb 1083 | bsz 37.8 | num_updates 3749 | best_bleu 67.76
2021-01-16 18:10:10 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:10:26 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 27 @ 3749 updates, score 67.76) (writing took 16.25096342014149 seconds)
2021-01-16 18:10:26 | INFO | fairseq_cli.train | end of epoch 27 (average epoch stats below)
2021-01-16 18:10:26 | INFO | train | epoch 027 | loss 2.566 | nll_loss 0.713 | ppl 1.64 | wps 7722.3 | ups 3.14 | wpb 2458.3 | bsz 71.9 | num_updates 3749 | lr 4.68625e-06 | gnorm 1.964 | loss_scale 8 | train_wall 24 | wall 1241
2021-01-16 18:10:26 | INFO | fairseq_cli.train | begin training epoch 27
2021-01-16 18:10:35 | INFO | train_inner | epoch 028:     51 / 139 loss=2.563, nll_loss=0.708, ppl=1.63, wps=6325.6, ups=2.67, wpb=2366.9, bsz=69.9, num_updates=3800, lr=4.75e-06, gnorm=1.996, loss_scale=8, train_wall=17, wall=1249
2021-01-16 18:10:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:10:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:10:51 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:10:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-16 18:10:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:10:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-16 18:10:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:10:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (one study involving 182 patients) .The studies compared Actrapid with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-16 18:10:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:10:54 | INFO | valid | epoch 028 | valid on 'valid' subset | loss 2.763 | nll_loss 0.866 | ppl 1.82 | bleu 68.21 | wps 997 | wpb 1083 | bsz 37.8 | num_updates 3888 | best_bleu 68.21
2021-01-16 18:10:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:11:11 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 28 @ 3888 updates, score 68.21) (writing took 16.363233235199004 seconds)
2021-01-16 18:11:11 | INFO | fairseq_cli.train | end of epoch 28 (average epoch stats below)
2021-01-16 18:11:11 | INFO | train | epoch 028 | loss 2.538 | nll_loss 0.68 | ppl 1.6 | wps 7706.9 | ups 3.14 | wpb 2458.3 | bsz 71.9 | num_updates 3888 | lr 4.86e-06 | gnorm 1.889 | loss_scale 8 | train_wall 24 | wall 1285
2021-01-16 18:11:11 | INFO | fairseq_cli.train | begin training epoch 28
2021-01-16 18:11:13 | INFO | train_inner | epoch 029:     12 / 139 loss=2.532, nll_loss=0.673, ppl=1.59, wps=6611.1, ups=2.65, wpb=2495.8, bsz=74.3, num_updates=3900, lr=4.875e-06, gnorm=1.864, loss_scale=8, train_wall=17, wall=1287
2021-01-16 18:11:30 | INFO | train_inner | epoch 029:    112 / 139 loss=2.51, nll_loss=0.649, ppl=1.57, wps=14195.7, ups=5.88, wpb=2413.2, bsz=68.1, num_updates=4000, lr=5e-06, gnorm=1.873, loss_scale=8, train_wall=17, wall=1304
2021-01-16 18:11:34 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:11:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-16 18:11:35 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:11:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-16 18:11:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:11:37 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:11:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:11:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients), in which Actrapid was compared to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood is glucose controlled, for six months.
2021-01-16 18:11:39 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:11:39 | INFO | valid | epoch 029 | valid on 'valid' subset | loss 2.745 | nll_loss 0.845 | ppl 1.8 | bleu 70.24 | wps 967.6 | wpb 1083 | bsz 37.8 | num_updates 4027 | best_bleu 70.24
2021-01-16 18:11:39 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:11:56 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 29 @ 4027 updates, score 70.24) (writing took 16.725813260301948 seconds)
2021-01-16 18:11:56 | INFO | fairseq_cli.train | end of epoch 29 (average epoch stats below)
2021-01-16 18:11:56 | INFO | train | epoch 029 | loss 2.509 | nll_loss 0.647 | ppl 1.57 | wps 7613.8 | ups 3.1 | wpb 2458.3 | bsz 71.9 | num_updates 4027 | lr 4.98321e-06 | gnorm 1.852 | loss_scale 8 | train_wall 24 | wall 1330
2021-01-16 18:11:56 | INFO | fairseq_cli.train | begin training epoch 29
2021-01-16 18:12:08 | INFO | train_inner | epoch 030:     73 / 139 loss=2.486, nll_loss=0.622, ppl=1.54, wps=6499.8, ups=2.62, wpb=2483.5, bsz=78, num_updates=4100, lr=4.93865e-06, gnorm=1.798, loss_scale=8, train_wall=17, wall=1342
2021-01-16 18:12:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-16 18:12:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:12:20 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-16 18:12:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-16 18:12:21 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-16 18:12:22 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:12:22 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-16 18:12:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients), in which Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood is glucose controlled, for six months.
2021-01-16 18:12:24 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-16 18:12:24 | INFO | valid | epoch 030 | valid on 'valid' subset | loss 2.726 | nll_loss 0.823 | ppl 1.77 | bleu 72.03 | wps 1015.3 | wpb 1083 | bsz 37.8 | num_updates 4166 | best_bleu 72.03
2021-01-16 18:12:24 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-16 18:12:41 | INFO | fairseq.checkpoint_utils | saved checkpoint checkpoints/EMEA_15/checkpoint_best.pt (epoch 30 @ 4166 updates, score 72.03) (writing took 17.58335837908089 seconds)
2021-01-16 18:12:41 | INFO | fairseq_cli.train | end of epoch 30 (average epoch stats below)
2021-01-16 18:12:41 | INFO | train | epoch 030 | loss 2.48 | nll_loss 0.615 | ppl 1.53 | wps 7492.3 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 4166 | lr 4.89937e-06 | gnorm 1.782 | loss_scale 8 | train_wall 24 | wall 1375
2021-01-16 18:12:41 | INFO | fairseq_cli.train | done training in 1366.6 seconds


###############################################################################
Peregrine Cluster
Job 17242484 for user 's3475743'
Finished at: Sat Jan 16 18:12:44 CET 2021

Job details:
============

Job ID              : 17242484
Name                : EMEA_15
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu31
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-16T17:38:08
Start               : 2021-01-16T17:49:03
End                 : 2021-01-16T18:12:44
Reserved walltime   : 23:55:00
Used walltime       : 00:23:41
Used CPU time       : 00:23:07 (efficiency:  8.14%)
% User (Computation): 50.62%
% System (I/O)      : 49.38%
Mem reserved        : 32G/node
Max Mem used        : 5.60G (pg-gpu31)
Max Disk Write      : 40.96K (pg-gpu31)
Max Disk Read       : 2.30M (pg-gpu31)
Average GPU usage   : 44.5% (pg-gpu31)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
